390 related articles for article (PubMed ID: 22298638)
1. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
Hu Z; Dong J; Wang LE; Ma H; Liu J; Zhao Y; Tang J; Chen X; Dai J; Wei Q; Zhang C; Shen H
Carcinogenesis; 2012 Apr; 33(4):828-34. PubMed ID: 22298638
[TBL] [Abstract][Full Text] [Related]
2. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.
Li LM; Hu ZB; Zhou ZX; Chen X; Liu FY; Zhang JF; Shen HB; Zhang CY; Zen K
Cancer Res; 2010 Dec; 70(23):9798-807. PubMed ID: 21098710
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
[TBL] [Abstract][Full Text] [Related]
5. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
6. U6 is not a suitable endogenous control for the quantification of circulating microRNAs.
Xiang M; Zeng Y; Yang R; Xu H; Chen Z; Zhong J; Xie H; Xu Y; Zeng X
Biochem Biophys Res Commun; 2014 Nov; 454(1):210-4. PubMed ID: 25450382
[TBL] [Abstract][Full Text] [Related]
7. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of circulating miRNA-21 and miRNA-146a in plasma samples of breast cancer patients.
Kumar S; Keerthana R; Pazhanimuthu A; Perumal P
Indian J Biochem Biophys; 2013 Jun; 50(3):210-4. PubMed ID: 23898484
[TBL] [Abstract][Full Text] [Related]
9. Decreased serum miR-181a is a potential new tool for breast cancer screening.
Guo LJ; Zhang QY
Int J Mol Med; 2012 Sep; 30(3):680-6. PubMed ID: 22692639
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
Heneghan HM; Miller N; Lowery AJ; Sweeney KJ; Newell J; Kerin MJ
Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
[TBL] [Abstract][Full Text] [Related]
12. Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma.
Fang C; Zhu DX; Dong HJ; Zhou ZJ; Wang YH; Liu L; Fan L; Miao KR; Liu P; Xu W; Li JY
Ann Hematol; 2012 Apr; 91(4):553-9. PubMed ID: 21987025
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
14. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer.
Liu H; Zhu L; Liu B; Yang L; Meng X; Zhang W; Ma Y; Xiao H
Cancer Lett; 2012 Mar; 316(2):196-203. PubMed ID: 22169097
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue.
Mar-Aguilar F; Luna-Aguirre CM; Moreno-Rocha JC; Araiza-Chávez J; Trevino V; Rodríguez-Padilla C; Reséndez-Pérez D
Asia Pac J Clin Oncol; 2013 Mar; 9(1):53-9. PubMed ID: 22898264
[TBL] [Abstract][Full Text] [Related]
18. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.
Wang H; Peng W; Ouyang X; Li W; Dai Y
Transl Res; 2012 Sep; 160(3):198-206. PubMed ID: 22683424
[TBL] [Abstract][Full Text] [Related]
20. Altered profile of serum microRNAs in pancreatic cancer-associated new-onset diabetes mellitus.
Dai X; Pang W; Zhou Y; Yao W; Xia L; Wang C; Chen X; Zen K; Zhang CY; Yuan Y
J Diabetes; 2016 May; 8(3):422-33. PubMed ID: 25991015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]